Jennifer Johnson, Head of Legal and IP, Blaze Bioscience
Farah Gerdes, Partner, Wilson Sonsini Goodrich & Rosati
Melissa Harwood, Senior Associate, Wilson Sonsini Goodrich & Rosati
The panelists will discuss:
• The interface between IP and license agreements in the biotech industry
• How changes in the patent landscape have impacted agreement terms and structure, e.g. value, strategy, economic structures
Early Bird by March 18 Regular and On-Site
LES Member: $20 LES Member: $25
Non-Member: $25 Non-Member: $30
Student/Unemployed: $15 Student/Unemployed: $15
About the Panelists:
Dr. Melissa Harwood is a senior associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on strategic patent counseling, patent prosecution, patent due diligence, patent-related dispute resolution, and intellectual property transactions for clients in the life sciences industries. She advises clients at all stages of development from proof of concept through market approval. Melissa specializes in chemical and biotechnology patent matters, including small molecule and biological therapeutics, immunology, diagnostics, nanotechnology, genomics, personalized medicine, and clean energy technologies.
Ms. Jennifer Johnson, J.D. is an experienced corporate and IP attorney with over 19 years of diverse legal experience in human biotechnology and agriculture companies. Prior to joining Blaze Bioscience, Ms. Johnson served as Head, Biology and Traits at Syngenta. Prior to Syngenta, she served in as Chief IP Counsel for ZymoGenetics. Previous to her life as a lawyer she was a researcher.
Ms. Johnson holds a BA degree from the University of California - Berkeley, an MS from the University of Washington, and a JD from the University of Washington Law School.
Farah Gerdes is a partner in the technology transactions practice at Wilson Sonsini Goodrich & Rosati, where she focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in intellectual property transactions. She represents clients in a variety of domestic and international business transactions involving intellectual property or product rights, including intellectual property licenses, collaboration agreements, research and development agreements, clinical trial management, manufacturing agreements, supply and distribution agreements, university licenses, mergers and acquisitions, and the formation of joint ventures and other types of strategic alliances and partnering arrangements. As a complement to her transactional IP practice, Farah advises her life sciences clients on a variety of FDA regulatory and healthcare issues, such as strategies for obtaining FDA product approvals and clearances, fraud and abuse, compliance, HIPAA, and claims support for advertising and promotional materials.
Direct questions to:
Director of Licensing
Washington Research Foundation